|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 47/68 | (2017.08) | ||
| C12N 15/13 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 16/3061 | (2013.01) | ||
| C12N 15/63 | (2006.01) | ||
| A61K 39/39558 | (2013.01) | ||
| C12N 7/01 | (2006.01) | ||
| C07K 14/7051 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K 19/00 | (2006.01) | ||
| C07K2317/565 | (2013.01) | ||
| C12N 5/10 | (2006.01) | ||
| C07K2317/622 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K 35/17 | (2025.01) | ||
| C12N2740/15043 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| G01N 33/57426 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| G01N 33/6854 | (2013.01) | ||
| C07K 14/725 | (2006.01) | ||
| A61K2239/46 | (2023.05) | ||
| C07K 16/30 | (2006.01) | ||
| A61K2239/31 | (2023.05) | ||
| C12N 15/62 | (2006.01) | ||
| A61K2239/38 | (2023.05) | ||
| C12N 5/0636 | (2013.01) | ||
| A61K 40/36 | (2025.01) | ||
| A61K 40/4215 | (2025.01) | ||
| A61K 40/31 | (2025.01) | ||
| A61K 40/11 | (2025.01) |
| (11) | Number of the document | 3572427 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18741764.7 |
| Date of filing the European patent application | 2018-01-23 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2025-06-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2018/073863 |
| Date | 2018-01-23 |
| (87) | Number | WO 2018/133877 |
| Date | 2018-07-26 |
| (30) | Number | Date | Country code |
| 201710058581 | 2017-01-23 | CN | |
| 201710920346 | 2017-09-30 | CN |
| (72) |
WANG, Peng , CN
WANG, Huamao , CN
JIANG, Hua , CN
|
| (73) |
CRAGE medical Co., Limited ,
RM12, 20/F, Ho King Comm CTR 2-16 FaYuen ST, Mongkok Kowloon Hong-Kong,
CN
|
| (54) | BCMA-TARGETING ANTIBODY AND USE THEREOF |
| BCMA-TARGETING ANTIBODY AND USE THEREOF |